Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): An international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention

Philippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, Frédéric Lapostolle, Dariusz Dudek, Martial Hamon, Claudio Cavallini, Giovanni Gordini, Kurt Huber, Pierre Coste, Michel Thicoipe, Lutz Nibbe, Jacob Steinmetz, Jurrien Ten Berg, Gerrit Jan Eggink, Uwe Zeymer, Marco Campo Dell' Orto, Vojko Kanic, Efthymios N Deliargyris, Jonathan DayDiana Schuette, Christian W Hamm, Patrick Goldstein

14 Citationer (Scopus)

Abstract

In patients with ST-segment elevation myocardial infarction (STEMI) triaged to primary percutaneous coronary intervention (PCI), anticoagulation often is initiated in the ambulance during transfer to a PCI site. In this prehospital setting, bivalirudin has not been compared with standard-of-care anticoagulation. In addition, it has not been tested in conjunction with the newer P2Y12 inhibitors prasugrel or ticagrelor.
OriginalsprogEngelsk
TidsskriftAmerican Heart Journal
Vol/bind166
Udgave nummer6
Sider (fra-til)960-967.e6
ISSN0002-8703
DOI
StatusUdgivet - dec. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): An international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention'. Sammen danner de et unikt fingeraftryk.

Citationsformater